基于肺癌分類標準演變對肺炎型肺癌的新認識_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

陳佳怡 ,  梁宗安

Corresponding?author：

梁宗安, Email: liang.zongan@163.com

Keywords：

DOI：

10.7507/1671-6205.201803021

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 陳佳怡, 梁宗安. 基于肺癌分類標準演變對肺炎型肺癌的新認識. Chinese Journal of Respiratory and Critical Care Medicine, 2018, 17(6): 633-638. doi: 10.7507/1671-6205.201803021 Copy

1.	Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108.
2.	Zheng R, Zeng H, Zuo T, et al. Lung cancer incidence and mortality in China, 2011. Thoracic cancer, 2016, 7(1): 94-99.
3.	Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010, 127(12): 2893-2917.
4.	Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin roentgenol, 2005, 40(2): 90-97.
5.	Butt YM, Allen TC. Yasmeen The demise of the term bronchioloalveolar carcinoma. Arch Pathol Lab Med, 2015, 139(8): 981-983.
6.	Zell JA, Ou SH, Ziogas A, et al. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol, 2005, 23(33): 8396-8405.
7.	Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc, 2011, 8(5): 381-385.
8.	Detterbeck FC, Marom EM, Arenberg DA, et al. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification. J Thorac Oncol, 2016, 11(5): 666-680.
9.	Raz DJ, Jablons DM. Bronchioloalveolar carcinoma is not associated with younger age at diagnosis: an analysis of the SEER database. J Thorac Oncol, 2006, 1(4): 339-343.
10.	Kim HY, Shim YM, Lee KS, et al. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology, 2007, 245(1): 267-275.
11.	Hjelmborg J, Korhonen T, Holst K, et al. Lung cancer, genetic predisposition and smoking: the Nordic Twin Study of Cancer. Thorax, 2017, 72(11): 1021-1027.
12.	Lopez Encuentra A, Pozo Rodriguez F, Martin de Nicolas JL, et al. Bronchioloalveolar carcinoma in Spain: a rare and different form of lung cancer. Arch bronconeumol, 2006, 42(8): 399-403.
13.	Camus M, Siemiatycki J, Meek B. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Engl J Med, 1998, 338(22): 1565-1571.
14.	Darby S, Hill D, Auvinen A, et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ, 2005, 330(7485): 223.
15.	Barone-Adesi F, Chapman RS, Silverman DT, et al. Risk of lung cancer associated with domestic use of coal in Xuanwei, China: retrospective cohort study. BMJ, 2012, 345: e5414.
16.	Kurmi OP, Arya PH, Lam KB, et al. Lung cancer risk and solid fuel smoke exposure: a systematic review and meta-analysis. Eur Respir J, 2012, 40(5): 1228-1237.
17.	Barcenas CH, Delclos GL, El-Zein R, et al. Wood dust exposure and the association with lung cancer risk. Am J Ind Med, 2005, 47(4): 349-357.
18.	Arrieta O, Martinez-Barrera L, Trevino S, et al. Wood-smoke exposure as a response and survival predictor in erlotinib-treated non-small cell lung cancer patients: an open label phase II study. J Thorac Oncol, 2008, 3(8): 887-893.
19.	Bode AM, Dong Z, Wang H. Cancer prevention and control: alarming challenges in China. Nati Sci Rev, 2016, 3(1): 117-127.
20.	Jia PL, Zhang C, Yu JJ, et al. The risk of lung cancer among cooking adults: a meta-analysis of 23 observational studies. J Cancer Res Clin Oncol, 2018, 144(2): 229-240.
21.	Yang Y, Fujita J, Tokuda M, et al. Lung cancer associated with several connective tissue diseases: with a review of literature. Rheumatol Int, 2001, 21(3): 106-111.
22.	Hopkins RJ, Duan F, Chiles C, et al. Reduced expiratory flow rate among heavy smokers increases lung cancer risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort. Ann Am Thorac Soc, 2017, 14(3): 392-402.
23.	Buchbinder R, Hill CL. Malignancy in patients with inflammatory myopathy. Curr Rheumatol Rep, 2002, 4(5): 415-426.
24.	Rodriguez-Lara V, Hernandez-Martinez JM, Arrieta O. Influence of estrogen in non-small cell lung cancer and its clinical implications. J Thorac Dis, 2018, 10(1): 482-497.
25.	Cheng TD, Darke AK, Redman MW, et al. Smoking, sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue. J Natl Cancer Inst, 2018, 110(7): 734-742.
26.	Wislez M, Massiani MA, Milleron B, et al. Clinical characteristics of pneumonic-type adenocarcinoma of the lung. Chest, 2003, 123(6): 1868-1877.
27.	Popat N, Raghavan N, Mclvor RA. Severe bronchorrhea in a patient with bronchioloalveolar carcinoma. Chest, 2012, 141(2): 513-514.
28.	Remi C, Remi J, Bausewein C. Pharmacological management of bronchorrhea in malignant disease: a systematic literature review. J Pain Symptom Manage, 2016, 51(5): 916-925.
29.	Inamura K. Clinicopathological characteristics and mutations driving development of early lung adenocarcinoma: tumor initiation and progression. Int J Mol Sci, 2018, 19(4): 1259-1264.
30.	Travis WD. Pathology of Lung Cancer. Clin Chest Med, 2011, 32(4): 669-692.
31.	Cha YJ, Shim HS. Biology of invasive mucinous adenocarcinoma of the lung. Transl Lung Cancer Res, 2017, 6(5): 508-512.
32.	Garfield DH, Cadranel J, West HL. Bronchioloalveolar carcinoma: the case for two diseases. Clin lung cancer, 2008, 9(1): 24-29.
33.	Raptis CA, Robb CL, Bhalla S. Tumor Staging of Lung Cancer: Essential Concepts for the Radiologist. Radiol Clin North Am, 2018, 56(3): 391-398.
34.	Jung JI, Kim H, Park SH, et al. CT differentiation of pneumonic-type bronchioloalveolar cell carcinoma and infectious pneumonia. Br J Radiol, 2001, 74(882): 490-494.
35.	Zwirewich CV, Miller RR, Muller NL. Multicentric adenocarcinoma of the lung: CT-pathologic correlation. Radiology, 1990, 176(1): 185-190.
36.	Liu YY, Chen YM, Huang MH, et al. Prognosis and recurrent patterns in bronchioloalveolar carcinoma. Chest, 2000, 118(4): 940-947.
37.	Ambrosini V, Nicolini S, Caroli P, et al. PET/CT imaging in different types of lung cancer: an overview. Eur J Radiol, 2012, 81(5): 988-1001.
38.	Detterbeck FC, Boffa DJ, Kim AW, et al. The Eighth Edition Lung Cancer Stage Classification. Chest, 2017, 151(1): 193-203.
39.	Breathnach OS, Ishibe N, Williams J, et al. Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung. Cancer, 1999, 86(7): 1165-1173.
40.	Cabanero M, Tsao MS. Circulating tumour DNA in EGFR-mutant non-small-cell lung cancer. Curr Oncol, 2018, 25(S1): 38-44.
41.	Raz DJ, Kim JY, Jablons DM. Diagnosis and treatment of bronchioloalveolar carcinoma. Curr Opin Pulm Med, 2007, 13(4): 290-296.
42.	Ebright MI, Zakowski MF, Martin J, et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Ann Thorac Surg, 2002, 74(5): 1640-1647.
43.	Whitson BA, Groth SS, Andrade RS, et al. Invasive adenocarcinoma with bronchoalveolar features: a population-based evaluation of the extent of resection in bronchoalveolar cell carcinoma. J Thorac Cardiovasc Surg, 2012, 143(3): 591-600.
44.	Ahmad U, Wang Z, Bryant AS, et al. Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry. Ann Thorac Surg, 2012, 94(3): 935-941.
45.	Scagliotti GV, Smit E, Bosquee L, et al. A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956). Lung cancer, 2005, 50(1): 91-96.
46.	Lau DH, Moon J, Davies AM, et al. Southwestern oncology group phase II trial (S0526) of pemetrexed in bronchioloalveolar carcinoma subtypes of advanced adenocarcinoma. Clin lung cancer, 2013, 14(4): 351-355.
47.	Yamakawa H, Takayanagi N, Ishiguro T, et al. A favorable response to cisplatin, pemetrexed and bevacizumab in two cases of invasive mucinous adenocarcinoma formerly known as pneumonic-type mucinous bronchioloalveolar carcinoma. Intern Med, 2013, 52(24): 2781-2784.
48.	Greenhalgh J, Dwan K, Boland A, et al. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer. Cochrane Database Syst Rev, 2016, 25(5): CD010383.
49.	Finberg KE, Sequist LV, Joshi VA, et al. Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchiolo -alveolar features. J Mol Diagn, 2007, 9(3): 320-326.
50.	Zell JA, Ou SH, Ziogas A, et al. Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis. Ann Oncol, 2006, 17(8): 1255-1262.
51.	Casali C, Rossi G, Marchioni A, et al. A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: clinicopathologic analysis, molecular features, and possible pitfalls in routine practice. J Thorac Oncol, 2010, 5(6): 830-836.

1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108.
2. Zheng R, Zeng H, Zuo T, et al. Lung cancer incidence and mortality in China, 2011. Thoracic cancer, 2016, 7(1): 94-99.
3. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010, 127(12): 2893-2917.
4. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin roentgenol, 2005, 40(2): 90-97.
5. Butt YM, Allen TC. Yasmeen The demise of the term bronchioloalveolar carcinoma. Arch Pathol Lab Med, 2015, 139(8): 981-983.
6. Zell JA, Ou SH, Ziogas A, et al. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol, 2005, 23(33): 8396-8405.
7. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc, 2011, 8(5): 381-385.
8. Detterbeck FC, Marom EM, Arenberg DA, et al. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification. J Thorac Oncol, 2016, 11(5): 666-680.
9. Raz DJ, Jablons DM. Bronchioloalveolar carcinoma is not associated with younger age at diagnosis: an analysis of the SEER database. J Thorac Oncol, 2006, 1(4): 339-343.
10. Kim HY, Shim YM, Lee KS, et al. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology, 2007, 245(1): 267-275.
11. Hjelmborg J, Korhonen T, Holst K, et al. Lung cancer, genetic predisposition and smoking: the Nordic Twin Study of Cancer. Thorax, 2017, 72(11): 1021-1027.
12. Lopez Encuentra A, Pozo Rodriguez F, Martin de Nicolas JL, et al. Bronchioloalveolar carcinoma in Spain: a rare and different form of lung cancer. Arch bronconeumol, 2006, 42(8): 399-403.
13. Camus M, Siemiatycki J, Meek B. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Engl J Med, 1998, 338(22): 1565-1571.
14. Darby S, Hill D, Auvinen A, et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ, 2005, 330(7485): 223.
15. Barone-Adesi F, Chapman RS, Silverman DT, et al. Risk of lung cancer associated with domestic use of coal in Xuanwei, China: retrospective cohort study. BMJ, 2012, 345: e5414.
16. Kurmi OP, Arya PH, Lam KB, et al. Lung cancer risk and solid fuel smoke exposure: a systematic review and meta-analysis. Eur Respir J, 2012, 40(5): 1228-1237.
17. Barcenas CH, Delclos GL, El-Zein R, et al. Wood dust exposure and the association with lung cancer risk. Am J Ind Med, 2005, 47(4): 349-357.
18. Arrieta O, Martinez-Barrera L, Trevino S, et al. Wood-smoke exposure as a response and survival predictor in erlotinib-treated non-small cell lung cancer patients: an open label phase II study. J Thorac Oncol, 2008, 3(8): 887-893.
19. Bode AM, Dong Z, Wang H. Cancer prevention and control: alarming challenges in China. Nati Sci Rev, 2016, 3(1): 117-127.
20. Jia PL, Zhang C, Yu JJ, et al. The risk of lung cancer among cooking adults: a meta-analysis of 23 observational studies. J Cancer Res Clin Oncol, 2018, 144(2): 229-240.
21. Yang Y, Fujita J, Tokuda M, et al. Lung cancer associated with several connective tissue diseases: with a review of literature. Rheumatol Int, 2001, 21(3): 106-111.
22. Hopkins RJ, Duan F, Chiles C, et al. Reduced expiratory flow rate among heavy smokers increases lung cancer risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort. Ann Am Thorac Soc, 2017, 14(3): 392-402.
23. Buchbinder R, Hill CL. Malignancy in patients with inflammatory myopathy. Curr Rheumatol Rep, 2002, 4(5): 415-426.
24. Rodriguez-Lara V, Hernandez-Martinez JM, Arrieta O. Influence of estrogen in non-small cell lung cancer and its clinical implications. J Thorac Dis, 2018, 10(1): 482-497.
25. Cheng TD, Darke AK, Redman MW, et al. Smoking, sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue. J Natl Cancer Inst, 2018, 110(7): 734-742.
26. Wislez M, Massiani MA, Milleron B, et al. Clinical characteristics of pneumonic-type adenocarcinoma of the lung. Chest, 2003, 123(6): 1868-1877.
27. Popat N, Raghavan N, Mclvor RA. Severe bronchorrhea in a patient with bronchioloalveolar carcinoma. Chest, 2012, 141(2): 513-514.
28. Remi C, Remi J, Bausewein C. Pharmacological management of bronchorrhea in malignant disease: a systematic literature review. J Pain Symptom Manage, 2016, 51(5): 916-925.
29. Inamura K. Clinicopathological characteristics and mutations driving development of early lung adenocarcinoma: tumor initiation and progression. Int J Mol Sci, 2018, 19(4): 1259-1264.
30. Travis WD. Pathology of Lung Cancer. Clin Chest Med, 2011, 32(4): 669-692.
31. Cha YJ, Shim HS. Biology of invasive mucinous adenocarcinoma of the lung. Transl Lung Cancer Res, 2017, 6(5): 508-512.
32. Garfield DH, Cadranel J, West HL. Bronchioloalveolar carcinoma: the case for two diseases. Clin lung cancer, 2008, 9(1): 24-29.
33. Raptis CA, Robb CL, Bhalla S. Tumor Staging of Lung Cancer: Essential Concepts for the Radiologist. Radiol Clin North Am, 2018, 56(3): 391-398.
34. Jung JI, Kim H, Park SH, et al. CT differentiation of pneumonic-type bronchioloalveolar cell carcinoma and infectious pneumonia. Br J Radiol, 2001, 74(882): 490-494.
35. Zwirewich CV, Miller RR, Muller NL. Multicentric adenocarcinoma of the lung: CT-pathologic correlation. Radiology, 1990, 176(1): 185-190.
36. Liu YY, Chen YM, Huang MH, et al. Prognosis and recurrent patterns in bronchioloalveolar carcinoma. Chest, 2000, 118(4): 940-947.
37. Ambrosini V, Nicolini S, Caroli P, et al. PET/CT imaging in different types of lung cancer: an overview. Eur J Radiol, 2012, 81(5): 988-1001.
38. Detterbeck FC, Boffa DJ, Kim AW, et al. The Eighth Edition Lung Cancer Stage Classification. Chest, 2017, 151(1): 193-203.
39. Breathnach OS, Ishibe N, Williams J, et al. Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung. Cancer, 1999, 86(7): 1165-1173.
40. Cabanero M, Tsao MS. Circulating tumour DNA in EGFR-mutant non-small-cell lung cancer. Curr Oncol, 2018, 25(S1): 38-44.
41. Raz DJ, Kim JY, Jablons DM. Diagnosis and treatment of bronchioloalveolar carcinoma. Curr Opin Pulm Med, 2007, 13(4): 290-296.
42. Ebright MI, Zakowski MF, Martin J, et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Ann Thorac Surg, 2002, 74(5): 1640-1647.
43. Whitson BA, Groth SS, Andrade RS, et al. Invasive adenocarcinoma with bronchoalveolar features: a population-based evaluation of the extent of resection in bronchoalveolar cell carcinoma. J Thorac Cardiovasc Surg, 2012, 143(3): 591-600.
44. Ahmad U, Wang Z, Bryant AS, et al. Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry. Ann Thorac Surg, 2012, 94(3): 935-941.
45. Scagliotti GV, Smit E, Bosquee L, et al. A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956). Lung cancer, 2005, 50(1): 91-96.
46. Lau DH, Moon J, Davies AM, et al. Southwestern oncology group phase II trial (S0526) of pemetrexed in bronchioloalveolar carcinoma subtypes of advanced adenocarcinoma. Clin lung cancer, 2013, 14(4): 351-355.
47. Yamakawa H, Takayanagi N, Ishiguro T, et al. A favorable response to cisplatin, pemetrexed and bevacizumab in two cases of invasive mucinous adenocarcinoma formerly known as pneumonic-type mucinous bronchioloalveolar carcinoma. Intern Med, 2013, 52(24): 2781-2784.
48. Greenhalgh J, Dwan K, Boland A, et al. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer. Cochrane Database Syst Rev, 2016, 25(5): CD010383.
49. Finberg KE, Sequist LV, Joshi VA, et al. Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchiolo -alveolar features. J Mol Diagn, 2007, 9(3): 320-326.
50. Zell JA, Ou SH, Ziogas A, et al. Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis. Ann Oncol, 2006, 17(8): 1255-1262.
51. Casali C, Rossi G, Marchioni A, et al. A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: clinicopathologic analysis, molecular features, and possible pitfalls in routine practice. J Thorac Oncol, 2010, 5(6): 830-836.

Previous Article
人 β-防御素和維生素 D 在社區獲得性肺炎中的臨床應用進展
Next Article
阻塞性睡眠呼吸暫停患者持續氣道正壓通氣治療相關吞氣癥和胃食管反流

Chinese Journal of Respiratory and Critical Care Medicine

基于肺癌分類標準演變對肺炎型肺癌的新認識

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content